Reducing Estrogen Dosing in CHC: The Quest to Balance Safety with Tolerability - a podcast by ReachMD

CME credits: 0.25

Valid until: 31-03-2022

Claim your CME credit at https://reachmd.com/programs/cme/reducing-estrogen-dosing-in-chc-the-quest-to-balance-safety-with-tolerability/12426/

Physicians continue to seek the safest and most effective formulations for combined hormonal contraceptives (CHCs). The goal is to ensure that the patient’s chosen option optimizes the many benefits of estrogen but also reduces its adverse events—particularly those that are cardiovascular and thromboembolic in nature. Lower estrogen concentrations do not always mean better; sometimes better means better. But just like in a game of beach limbo, we have to ask: How low can you go?

Join us as Dr. Lee Shulman and Barbara Dehn, a nurse practitioner with vast contraception counseling and prescribing experience, discuss the dynamics of a new, lower-strength estrogen with the potential for use in combined oral contraceptives.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD